Vintas Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -8.47%
- Profit Growth -41.63%
- Ebitda -56.85%
- Net Worth 12.51%
- Total Assets 9.47%
About Vintas Pharmaceuticals
Vintas Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 July 2015 (Nine years and six months 23 days old ). Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Varesh Khanna, Rahul Saini, and Munish Aggarwal serve as directors at the Company.
Company Details
-
Location
Ambala, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397HR2015PTC056046
-
Company No.
056046
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jul 2015
-
Date of AGM
05 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vintas Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varesh Khanna
|
Director | 14-Jul-2015 | Current |
|
Munish Aggarwal
|
Director | 14-Jul-2015 | Current |
|
Rahul Saini
|
Director | 14-Jul-2015 | Current |
Financial Performance of Vintas Pharmaceuticals.
Vintas Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.47% decrease. The company also saw a substantial fall in profitability, with a 41.63% decrease in profit. The company's net worth Soared by an impressive increase of 12.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vintas Pharmaceuticals?
Unlock access to Vintas Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Elivia Lifesciences Private LimitedMunish Aggarwal is a mutual person
-
Jenfer Biosciences Private LimitedVaresh Khanna and Munish Aggarwal are mutual person
-
Axodin Pharmaceuticals Private LimitedRahul Saini is a mutual person
-
Alisier Drugs Private LimitedVaresh Khanna is a mutual person
-
Shinor Herbals Private LimitedVaresh Khanna is a mutual person
-
Shinor Biosciences Private Limited
Varesh Khanna is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vintas Pharmaceuticals?
Unlock and access historical data on people associated with Vintas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vintas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vintas Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.